Samuel G. Levy
Director/Board Member at THERACLION
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Niels Erik Holm | M | - |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | 16 years |
| David W. Dockhorn | M | 63 |
Veranex, Inc.
 Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | 3 years |
| Avner Geva | M | - |
Vensica Medical Ltd.
 Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | 11 years |
| Martin Deterre | M | - | 4 years | |
| Patrick K. Donnelly | M | - |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | 3 years |
| Rasmus Lundquist | M | - |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | 16 years |
| Timothy Springer | M | 76 |
Harvard Medical School
| 13 years |
| C. Adair | M | - |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | 3 years |
| Edit Goldberg | M | - |
Vensica Medical Ltd.
Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | - |
| Keith Flaherty | M | 53 |
Harvard Medical School
| 15 years |
| Albert Hsia | M | - |
iXLife Capital SAS
 iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | 13 years |
| Michel Nuta | M | - | 11 years | |
| Mehdi El Glaoui | M | - | 3 years | |
| Marc Semigran | M | 67 |
Harvard Medical School
| 14 years |
| Marina Iché | F | - |
iXLife Capital SAS
iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | 16 years |
| Edoardo Fracchia | M | 39 |
Lauxera Capital Partners SAS
 Lauxera Capital Partners SAS Investment ManagersFinance Lauxera Capital Partners SAS is an Independent firm founded in 1992 by Samuel G. Levy. Lauxera Capital Partners SAS is headquartered in Paris. | 4 years |
| Ali L. Dowd | M | - |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | - |
| Shawn Langer | M | - | 5 years | |
| Milton Menahem Yisrael | M | 55 |
Vensica Medical Ltd.
Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | - |
| Jeremie Anquez | M | - | - | |
| Curtis L. Cetrulo | M | 54 |
Harvard Medical School
| 15 years |
| Alix De Benedetti | F | - |
Lauxera Capital Partners SAS
Lauxera Capital Partners SAS Investment ManagersFinance Lauxera Capital Partners SAS is an Independent firm founded in 1992 by Samuel G. Levy. Lauxera Capital Partners SAS is headquartered in Paris. | 2 years |
| Victor Decrion | M | - |
Lauxera Capital Partners SAS
Lauxera Capital Partners SAS Investment ManagersFinance Lauxera Capital Partners SAS is an Independent firm founded in 1992 by Samuel G. Levy. Lauxera Capital Partners SAS is headquartered in Paris. | 1 years |
| Søren Møller | M | 56 |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Cyrille Yann Nicolas Petit | M | 54 |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Marshall Stanton | M | 67 |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | - |
| Ari Kellen | M | - | 5 years | |
| Darren Black | M | 51 |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | - |
| Jørgen Ulrik Vejlsgaard | M | - |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Bo Jesper Hansen | M | 66 |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Uri Geiger | M | 56 |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | 2 years |
| Ulrik Spork | M | - |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Philippe de Bellefonds | M | - |
iXLife Capital SAS
iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | 23 years |
| Tonni Bülow-Nielsen | M | - |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Klaus Eldrup-Jørgensen | M | 65 |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Renaud Saleur | M | - | 6 years | |
| Gidon Zairi | M | - |
Vensica Medical Ltd.
Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | 3 years |
| Jean-Pierre Kinet | M | 70 |
iXLife Capital SAS
iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | 9 years |
| Graeme Brookes | M | - |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | 10 years |
| Laurence Géricot | F | - | - | |
| Yann Duchesne | M | 67 | 2 years | |
| Eran Feldhay | M | - |
Vensica Medical Ltd.
Vensica Medical Ltd. Medical SpecialtiesHealth Technology Vensica Medical Ltd. operates as a medical device company. It designs and develops ultrasound catheter for the treatment of bladder cancer. The firm creates a drug delivery platform to the urinary bladder using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, painfree, needlefree procedure in an office setting. The company was founded by Avner Geva in 2013 and is headquartered in Misgav, Israel. | - |
| Richard Michael Twomey | M | 60 |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | - |
| Gaylord Tallec | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| François Lacoste | M | - | 14 years | |
| Sylvain Yon | M | - | 10 years | |
| Annette Hasenburg | M | - | 4 years | |
| Christopher S. Bödtker | M | - | 2 years | |
| Amit Kakar | M | 59 | - | |
| Armand Sibony | M | - |
iXLife Capital SAS
iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | 14 years |
| Tilman B. Drueke | M | - | 6 years | |
| Lazlo Hegedüs | M | - | 6 years | |
| Bernd von Polheim | M | - | 7 years | |
| Laurent Levy | M | - | - | |
| Jeffery L. Kutok | M | 57 |
Harvard Medical School
| 8 years |
| Evan Caplan | M | - |
Harvard Medical School
| 5 years |
| Daniel Gebremedhin | M | - |
Harvard Medical School
| 9 years |
| Anne Klibanski | M | 73 |
Harvard Medical School
| - |
| Hyung-Gu Kim | M | 57 |
Harvard Medical School
| 8 years |
| Stephen Curtis | M | - |
Harvard Medical School
| 5 years |
| Pablo Cironi | M | - |
Harvard Medical School
| 4 years |
| Ben Robbins | M | - |
Harvard Medical School
| 6 years |
| Boris Nikolic | M | 54 |
Harvard Medical School
| 8 years |
| Yeang Chng | M | - |
Harvard Medical School
| 3 years |
| Kan Chen | M | 42 |
Harvard Medical School
| 3 years |
| Tariq Warsi | M | - |
Harvard Medical School
| 2 years |
| Vincent Ricchiuti | M | - |
Harvard Medical School
| 12 years |
| Edouard Mullarky | M | - |
Harvard Medical School
| 7 years |
| Christian Schubert | M | - |
Harvard Medical School
| 3 years |
| Anthony Philippakis | M | 48 |
Harvard Medical School
| 8 years |
| Frank Baldino | M | 71 |
Harvard Medical School
| - |
| Vincent Chen | M | - |
Harvard Medical School
| 3 years |
| Kush Parmar | M | 42 |
Harvard Medical School
| 8 years |
| Lijun Sun | M | 61 |
Harvard Medical School
| - |
| José Baselga | M | 65 |
Harvard Medical School
| 2 years |
| Lewis Cantley | M | 75 |
Harvard Medical School
| 20 years |
| Thomas Daulton | M | - |
Veranex, Inc.
Veranex, Inc. Information Technology ServicesTechnology Services Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021. | - |
| David Anderson | M | 54 |
Harvard Medical School
| - |
| Thomas Lynch | M | 63 |
Harvard Medical School
| 1 years |
| Krishna Yeshwant | M | 46 |
Harvard Medical School
| 5 years |
| Timothy Lu | M | 43 |
Harvard Medical School
| 2 years |
| Deborah A. Quinn | M | 69 |
Harvard Medical School
| 5 years |
| A. Sorensen | M | 62 |
Harvard Medical School
| 16 years |
| Jonathan L. Tilly | M | 61 |
Harvard Medical School
| - |
| Cassia van der Hoof Holstein | F | 47 |
Harvard Medical School
| 6 years |
| Wolfram Eichner | M | - | 2 years | |
| Shantanu Gaur | M | 37 |
Harvard Medical School
| 3 years |
| D. Gilliland | M | 69 |
Harvard Medical School
| - |
| Jean-Pierre Sommadossi | M | 68 |
Harvard Medical School
| 11 years |
| Elizabeth Nabel | M | 72 |
Harvard Medical School
| 11 years |
| Evelyne Bischof | M | - |
Harvard Medical School
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 47 | 51.65% |
| France | 28 | 30.77% |
| Denmark | 11 | 12.09% |
| Israel | 5 | 5.49% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Samuel G. Levy
- Personal Network